IDEXX Laboratories, Inc. (LON:0J8P)
London · Delayed Price · Currency is GBP · Price in USD 720.51
+19.19 (2.74%)
Jan 7, 2026, 5:00 PM GMT
IDEXX Laboratories Market Cap
IDEXX Laboratories has a market cap or net worth of 41.81 billion as of January 7, 2026. Its market cap has increased by 57.81% in one year.
Market Cap
41.81B
Enterprise Value
42.48B
Revenue
3.10B
Ranking
n/a
PE Ratio
54.70
Stock Price
720.51
Market Cap Chart
Since June 21, 1991, IDEXX Laboratories's market cap has increased from 42.95M to 41.81B, an increase of 97,239.33%. That is a compound annual growth rate of 22.02%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 6, 2026 | 41.81B | 4.17% |
| Dec 31, 2025 | 40.14B | 48.43% |
| Dec 31, 2024 | 27.04B | -25.28% |
| Dec 29, 2023 | 36.19B | 29.06% |
| Dec 30, 2022 | 28.04B | -32.00% |
| Dec 31, 2021 | 41.23B | 32.03% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| AstraZeneca | 207.55B |
| GSK plc | 73.04B |
| Haleon | 33.16B |
| Smith & Nephew | 10.43B |
| Convatec Group | 4.69B |
| Hikma Pharmaceuticals | 3.38B |
| HUTCHMED (China) | 1.74B |
| Genus | 1.69B |